Manganese induces the overexpression of α-synuclein in PC12 cells via ERK activation

Tongjian Cai1, Ting Yao, Gang Zheng

  • 1Department of Occupational and Environmental Health, School of Public Health, Fourth Military Medical University, Xi'an 710032, China.

Brain Research
|August 26, 2010
PubMed

Insights

Manganese exposure increases alpha-synuclein (α-synuclein) levels and causes cell damage. Reducing α-synuclein lessens this toxicity, suggesting a key role in manganese-induced neurological disorders.

Area of Science:

  • Neuroscience
  • Toxicology
  • Cell Biology

Background:

  • Manganese is a neurotoxic metal linked to neurological disorders.
  • Alpha-synuclein (α-synuclein) is implicated in neurodegenerative diseases.
  • The precise mechanisms of manganese neurotoxicity require further elucidation.

Purpose of the Study:

  • To investigate the effect of manganese on α-synuclein expression in PC12 cells.
  • To determine the role of α-synuclein in manganese-induced cytotoxicity.
  • To explore the relationship between α-synuclein and ERK1/2 MAPK signaling.

Main Methods:

  • PC12 cells were exposed to manganese.
  • Alpha-synuclein expression was modulated using siRNA.
  • Cell viability was assessed.
  • Extracellular signal-regulated kinase 1/2 (ERK1/2) mitogen-activated protein kinase (MAPK) activity was measured.
  • MEK1 inhibitor PD98059 was used to block ERK MAPK activation.

Main Results:

  • Manganese exposure led to α-synuclein overexpression.
  • siRNA-mediated knockdown of α-synuclein protected PC12 cells from manganese-induced cytotoxicity.
  • Manganese exposure activated ERK1/2 MAPK signaling.
  • Inhibition of ERK1/2 MAPK attenuated α-synuclein overexpression and cytotoxicity.

Conclusions:

  • Manganese may induce α-synuclein overexpression through ERK1/2 MAPK activation.
  • Alpha-synuclein plays a significant role in manganese-induced cytotoxicity.
  • Targeting the α-synuclein pathway may offer therapeutic strategies for manganese neurotoxicity.